Feasibility in the Prophylaxis of Radiation Dermatitis Severity

TerminatedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions
Radiation Dermatitis
Interventions
DRUG

StrataXRT

Patients will be asked to start topical application of their allocated topical preparation on the area of skin that will be irradiated at the onset of radiation therapy, every day until skin symptoms subside (see patient information pamphlet). Apply twice per day and can be reapplied as skin symptoms arise or as needed. The amount of StrataXRT provided to each patient will be recorded throughout treatment.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04715386 - Feasibility in the Prophylaxis of Radiation Dermatitis Severity | Biotech Hunter | Biotech Hunter